Hrt Financial LP Durect Corp Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.64 $9,256 - $15,589	24,359 New	24,359 $11,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.98 $31,008 - $55,251	-56,379 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.9 - $1.31 $50,741 - $73,856	56,379 New	56,379 $55,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $5,979 - $10,083	-11,725 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$0.51 - $0.82 $598 - $962	1,174 Added 11.13%	11,725 $7,000
Q4 2018 Feb 15, 2019	BUY	$0.48 - $1.1 $5,064 - $11,606	10,551 New	10,551 $5,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.